Showing results (321-330 of 333) with videos related to
Sort By:
Pageof 34
Human Cell|March 1, 1996
[Recombinant virus-mediated transfer of the wild-type p53 gene is a potent therapeutic strategy for human cancer]T Fujiwara, S Kagawa, N Ogawa, et al.Acta Medica Okayama|February 1, 1994
Ovarian metastasis in patients with colorectal carcinomaJ A Perdomo, A Hizuta, H Iwagaki, et al.American Journal of Human Genetics|July 1, 1976
HLA antigens in Japanese populationsN Yasuda, K Tsuji, M Aizawa, et al.Leukemia|September 26, 1997
Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23)Y Matsuo, R A MacLeod, C C Uphoff, et al.Leukemia|February 3, 1998
A novel ALL-L3 cell line, BALM-16, lacking expression of immunoglobulin chains derived from a patient with hypercalcemiaY Matsuo, R A MacLeod, K Kojima, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1982
[Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1]M Niimoto, T Hattori, I Itoh, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1983
[Clinical evaluation of schizophyllan (SPG) in advanced gastric cancer--a randomized comparative study by an envelope method]I Nakao, H Uchino, K Orita, et al.Investigational New Drugs|December 16, 1998
Phase II study of paclitaxel (BMS-181339) intravenously infused over 3 hours for advanced or metastatic breast cancer in Japan. BMS-181339 Breast Cancer Study GroupY Ito, N Horikoshi, T Watanabe, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1982
[Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-5-FU combination therapy with or without levamisole. 1]M Niimoto, T Hattori, I Itoh, et al.The Japanese Journal of Antibiotics|May 1, 1996
[Isolation rate of E. coli from surgical infections and their susceptibilities]N Shinagawa, J Yura, T Manabe, et al.Pageof 34